APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antibody Fragments

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Antibody Fragments Industry Growth and Trends Forecast to 2032

26 December 2025105 pages

Choose your research edition.

Industry ResearchAntibody Fragments Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Antibody Fragments Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Antibody Fragments Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antibody Fragments Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Antibody Fragments Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Antibody Fragments market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antibody Fragments is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antibody Fragments is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antibody Fragments is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antibody Fragments include AbbVie, Amgen, Biogen, Bristol-Myers Squibb, F. Hoffmann-La Roche, Eli Lilly, Novartis, Johnson & Johnson and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antibody Fragments market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antibody Fragments market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antibody Fragments market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antibody Fragments.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antibody Fragments market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antibody Fragments Market by Company

AbbVie

Amgen

Biogen

Bristol-Myers Squibb

F. Hoffmann-La Roche

Eli Lilly

Novartis

Johnson & Johnson

Sanofi

Takeda Pharmaceutical

Antibody Fragments Segment by Type

F(ab) Fragment

F(ab’)2 Fragment

Antibody Fragments Segment by Application

Cancer

Immunodeficiencies

Other

Antibody Fragments Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody Fragments market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antibody Fragments and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody Fragments.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antibody Fragments manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antibody Fragments in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of F(ab) Fragment Table 2. Major Company of F(ab’)2 Fragment Table 3. Global Antibody Fragments Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Antibody Fragments Sales by Type (2021-2026) & (W Units) Table 5. Global Antibody Fragments Sales Market Share in Volume by Type (2021-2026) Table 6. Global Antibody Fragments Sales by Type (2021-2026) & (US$ Million) Table 7. Global Antibody Fragments Sales Market Share in Value by Type (2021-2026) Table 8. Global Antibody Fragments Price by Type (2021-2026) & (US$/Unit) Table 9. Global Antibody Fragments Sales by Type (2027-2032) & (W Units) Table 10. Global Antibody Fragments Sales Market Share in Volume by Type (2027-2032) Table 11. Global Antibody Fragments Sales by Type (2027-2032) & (US$ Million) Table 12. Global Antibody Fragments Sales Market Share in Value by Type (2027-2032) Table 13. Global Antibody Fragments Price by Type (2027-2032) & (US$/Unit) Table 14. North America Antibody Fragments Sales by Type (2021-2026) & (W Units) Table 15. North America Antibody Fragments Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Antibody Fragments Sales by Type (2021-2026) & (W Units) Table 17. Europe Antibody Fragments Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Antibody Fragments Sales by Type (2021-2026) & (W Units) Table 19. Asia-Pacific Antibody Fragments Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Antibody Fragments Sales by Type (2021-2026) & (W Units) Table 21. Latin America Antibody Fragments Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Antibody Fragments Sales by Type (2021-2026) & (W Units) Table 23. Middle East and Africa Antibody Fragments Sales by Type (2021-2026) & (US$ Million) Table 24. Antibody Fragments Industry Trends Table 25. Antibody Fragments Industry Drivers Table 26. Antibody Fragments Industry Opportunities and Challenges Table 27. Antibody Fragments Industry Restraints Table 28. Global Antibody Fragments Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Antibody Fragments Revenue Market Share by Company (2021-2026) Table 30. Global Antibody Fragments Sales by Company (2021-2026) & (W Units) Table 31. Global Antibody Fragments Sales Share by Company (2021-2026) Table 32. Global Antibody Fragments Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Antibody Fragments Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Antibody Fragments Major Company Production Sites and Headquarters Table 35. Global Antibody Fragments Company, Product Type & Application Table 36. Global Antibody Fragments Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Antibody Fragments by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Antibody Fragments Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Antibody Fragments Sales by Region (2021-2026) & (W Units) Table 41. Global Antibody Fragments Sales Market Share in Volume by Region (2021-2026) Table 42. Global Antibody Fragments Sales by Region (2021-2026) & (US$ Million) Table 43. Global Antibody Fragments Sales Market Share in Value by Region (2021-2026) Table 44. Global Antibody Fragments Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Antibody Fragments Sales by Region (2027-2032) & (W Units) Table 46. Global Antibody Fragments Sales Market Share in Volume by Region (2027-2032) Table 47. Global Antibody Fragments Sales by Region (2027-2032) & (US$ Million) Table 48. Global Antibody Fragments Sales Market Share in Value by Region (2027-2032) Table 49. Global Antibody Fragments Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Antibody Fragments Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Antibody Fragments Sales by Application (2021-2026) & (W Units) Table 52. Global Antibody Fragments Sales Market Share in Volume by Application (2021-2026) Table 53. Global Antibody Fragments Sales by Application (2021-2026) & (US$ Million) Table 54. Global Antibody Fragments Sales Market Share in Value by Application (2021-2026) Table 55. Global Antibody Fragments Price by Application (2021-2026) & (US$/Unit) Table 56. Global Antibody Fragments Sales by Application (2027-2032) & (W Units) Table 57. Global Antibody Fragments Sales Market Share in Volume by Application (2027-2032) Table 58. Global Antibody Fragments Sales by Application (2027-2032) & (US$ Million) Table 59. Global Antibody Fragments Sales Market Share in Value by Application (2027-2032) Table 60. Global Antibody Fragments Price by Application (2027-2032) & (US$/Unit) Table 61. North America Antibody Fragments Sales by Application (2021-2026) & (W Units) Table 62. North America Antibody Fragments Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Antibody Fragments Sales by Application (2021-2026) & (W Units) Table 64. Europe Antibody Fragments Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Antibody Fragments Sales by Application (2021-2026) & (W Units) Table 66. Asia-Pacific Antibody Fragments Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Antibody Fragments Sales by Application (2021-2026) & (W Units) Table 68. Latin America Antibody Fragments Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Antibody Fragments Sales by Application (2021-2026) & (W Units) Table 70. Middle East and Africa Antibody Fragments Sales by Application (2021-2026) & (US$ Million) Table 71. AbbVie Company Information Table 72. AbbVie Business Overview Table 73. AbbVie Antibody Fragments Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. AbbVie Antibody Fragments Product Portfolio Table 75. AbbVie Recent Development Table 76. Amgen Company Information Table 77. Amgen Business Overview Table 78. Amgen Antibody Fragments Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Amgen Antibody Fragments Product Portfolio Table 80. Amgen Recent Development Table 81. Biogen Company Information Table 82. Biogen Business Overview Table 83. Biogen Antibody Fragments Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Biogen Antibody Fragments Product Portfolio Table 85. Biogen Recent Development Table 86. Bristol-Myers Squibb Company Information Table 87. Bristol-Myers Squibb Business Overview Table 88. Bristol-Myers Squibb Antibody Fragments Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Bristol-Myers Squibb Antibody Fragments Product Portfolio Table 90. Bristol-Myers Squibb Recent Development Table 91. F. Hoffmann-La Roche Company Information Table 92. F. Hoffmann-La Roche Business Overview Table 93. F. Hoffmann-La Roche Antibody Fragments Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. F. Hoffmann-La Roche Antibody Fragments Product Portfolio Table 95. F. Hoffmann-La Roche Recent Development Table 96. Eli Lilly Company Information Table 97. Eli Lilly Business Overview Table 98. Eli Lilly Antibody Fragments Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Eli Lilly Antibody Fragments Product Portfolio Table 100. Eli Lilly Recent Development Table 101. Novartis Company Information Table 102. Novartis Business Overview Table 103. Novartis Antibody Fragments Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Novartis Antibody Fragments Product Portfolio Table 105. Novartis Recent Development Table 106. Johnson & Johnson Company Information Table 107. Johnson & Johnson Business Overview Table 108. Johnson & Johnson Antibody Fragments Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Johnson & Johnson Antibody Fragments Product Portfolio Table 110. Johnson & Johnson Recent Development Table 111. Sanofi Company Information Table 112. Sanofi Business Overview Table 113. Sanofi Antibody Fragments Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Sanofi Antibody Fragments Product Portfolio Table 115. Sanofi Recent Development Table 116. Takeda Pharmaceutical Company Information Table 117. Takeda Pharmaceutical Business Overview Table 118. Takeda Pharmaceutical Antibody Fragments Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Takeda Pharmaceutical Antibody Fragments Product Portfolio Table 120. Takeda Pharmaceutical Recent Development Table 121. North America Antibody Fragments Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 122. North America Antibody Fragments Sales by Country (2021-2026) & (W Units) Table 123. North America Antibody Fragments Sales Market Share by Country (2021-2026) Table 124. North America Antibody Fragments Sales Forecast by Country (2027-2032) & (W Units) Table 125. North America Antibody Fragments Sales Market Share Forecast by Country (2027-2032) Table 126. North America Antibody Fragments Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Antibody Fragments Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Antibody Fragments Market Share by Country (2021-2026) Table 129. North America Antibody Fragments Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Antibody Fragments Market Share Forecast by Country (2027-2032) Table 131. Europe Antibody Fragments Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 132. Europe Antibody Fragments Sales by Country (2021-2026) & (W Units) Table 133. Europe Antibody Fragments Sales Market Share by Country (2021-2026) Table 134. Europe Antibody Fragments Sales Forecast by Country (2027-2032) & (W Units) Table 135. Europe Antibody Fragments Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Antibody Fragments Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Antibody Fragments Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Antibody Fragments Market Share by Country (2021-2026) Table 139. Europe Antibody Fragments Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Antibody Fragments Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Antibody Fragments Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Antibody Fragments Sales by Country (2021-2026) & (W Units) Table 143. Asia-Pacific Antibody Fragments Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Antibody Fragments Sales Forecast by Country (2027-2032) & (W Units) Table 145. Asia-Pacific Antibody Fragments Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Antibody Fragments Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Antibody Fragments Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Antibody Fragments Market Share by Country (2021-2026) Table 149. Asia-Pacific Antibody Fragments Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Antibody Fragments Market Share Forecast by Country (2027-2032) Table 151. Latin America Antibody Fragments Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 152. Latin America Antibody Fragments Sales by Country (2021-2026) & (W Units) Table 153. Latin America Antibody Fragments Sales Market Share by Country (2021-2026) Table 154. Latin America Antibody Fragments Sales Forecast by Country (2027-2032) & (W Units) Table 155. Latin America Antibody Fragments Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Antibody Fragments Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Antibody Fragments Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Antibody Fragments Market Share by Country (2021-2026) Table 159. Latin America Antibody Fragments Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Antibody Fragments Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Antibody Fragments Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Antibody Fragments Sales by Country (2021-2026) & (W Units) Table 163. Middle East and Africa Antibody Fragments Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Antibody Fragments Sales Forecast by Country (2027-2032) & (W Units) Table 165. Middle East and Africa Antibody Fragments Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Antibody Fragments Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Antibody Fragments Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Antibody Fragments Market Share by Country (2021-2026) Table 169. Middle East and Africa Antibody Fragments Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Antibody Fragments Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Antibody Fragments Distributors List Table 174. Antibody Fragments Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Antibody Fragments Image Figure 2. Global Antibody Fragments Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antibody Fragments Market Size (2021-2032) & (US$ Million) Figure 4. Global Antibody Fragments Sales (2021-2032) & (W Units) Figure 5. F(ab) Fragment Image Figure 6. Global F(ab) Fragment Sales YoY Growth (2021-2032) & (W Units) Figure 7. F(ab’)2 Fragment Image Figure 8. Global F(ab’)2 Fragment Sales YoY Growth (2021-2032) & (W Units) Figure 9. Global Antibody Fragments Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Antibody Fragments Market Share by Type 2025 VS 2032 Figure 11. North America Antibody Fragments Sales Market Share in Volume by Type in 2025 Figure 12. North America Antibody Fragments Sales Market Share in Value by Type in 2025 Figure 13. Europe Antibody Fragments Sales Market Share in Volume by Type in 2025 Figure 14. Europe Antibody Fragments Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Antibody Fragments Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Antibody Fragments Sales Market Share in Value by Type in 2025 Figure 17. Latin America Antibody Fragments Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Antibody Fragments Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Antibody Fragments Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Antibody Fragments Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Antibody Fragments Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Cancer Image Figure 24. Global Cancer Sales YoY Growth (2021-2032) & (W Units) Figure 25. Immunodeficiencies Image Figure 26. Global Immunodeficiencies Sales YoY Growth (2021-2032) & (W Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (W Units) Figure 29. Global Antibody Fragments Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Antibody Fragments Market Share by Application 2025 VS 2032 Figure 31. North America Antibody Fragments Sales Market Share in Volume by Application in 2025 Figure 32. North America Antibody Fragments Sales Market Share in Value by Application in 2025 Figure 33. Europe Antibody Fragments Sales Market Share in Volume by Application in 2025 Figure 34. Europe Antibody Fragments Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Antibody Fragments Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Antibody Fragments Sales Market Share in Value by Application in 2025 Figure 37. Latin America Antibody Fragments Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Antibody Fragments Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Antibody Fragments Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Antibody Fragments Sales Market Share in Value by Application in 2025 Figure 41. North America Antibody Fragments Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 42. North America Antibody Fragments Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Antibody Fragments Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Antibody Fragments Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Antibody Fragments Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. Europe Antibody Fragments Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Antibody Fragments Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Antibody Fragments Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Antibody Fragments Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Asia-Pacific Antibody Fragments Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Antibody Fragments Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Antibody Fragments Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Antibody Fragments Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Latin America Antibody Fragments Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Antibody Fragments Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Antibody Fragments Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Antibody Fragments Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Middle East and Africa Antibody Fragments Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Antibody Fragments Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Antibody Fragments Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Antibody Fragments Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Antibody Fragments Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • F(ab) Fragment
  • F(ab’)2 Fragment
Applications
  • Cancer
  • Immunodeficiencies
  • Other
Companies covered
  • AbbVie
  • Amgen
  • Biogen
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • Eli Lilly
  • Novartis
  • Johnson & Johnson
  • Sanofi
  • Takeda Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antibody Fragments Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antibody Fragments Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antibody Fragments Market by Type
  6. 1.3.1 F(ab) Fragment
  7. 1.3.2 F(ab’)2 Fragment
  8. 1.4 Global Antibody Fragments Market Size by Type
  9. 1.4.1 Global Antibody Fragments Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Antibody Fragments Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Antibody Fragments Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Antibody Fragments Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Antibody Fragments Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Antibody Fragments Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Antibody Fragments Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Antibody Fragments Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antibody Fragments Industry Trends
  2. 2.2 Antibody Fragments Industry Drivers
  3. 2.3 Antibody Fragments Industry Opportunities and Challenges
  4. 2.4 Antibody Fragments Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antibody Fragments Revenue (2021-2026)
  2. 3.2 Global Top Players by Antibody Fragments Sales (2021-2026)
  3. 3.3 Global Top Players by Antibody Fragments Price (2021-2026)
  4. 3.4 Global Antibody Fragments Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antibody Fragments Major Company Production Sites & Headquarters
  6. 3.6 Global Antibody Fragments Company, Product Type & Application
  7. 3.7 Global Antibody Fragments Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antibody Fragments Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antibody Fragments Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antibody Fragments Tier 1, Tier 2, and Tier 3
4 Antibody Fragments Regional Status and Outlook
  1. 4.1 Global Antibody Fragments Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antibody Fragments Historic Market Size by Region
  3. 4.2.1 Global Antibody Fragments Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antibody Fragments Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antibody Fragments Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antibody Fragments Forecasted Market Size by Region
  7. 4.3.1 Global Antibody Fragments Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antibody Fragments Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antibody Fragments Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antibody Fragments by Application
  1. 5.1 Antibody Fragments Market by Application
  2. 5.1.1 Cancer
  3. 5.1.2 Immunodeficiencies
  4. 5.1.3 Other
  5. 5.2 Global Antibody Fragments Market Size by Application
  6. 5.2.1 Global Antibody Fragments Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Antibody Fragments Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Antibody Fragments Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Antibody Fragments Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Antibody Fragments Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Antibody Fragments Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Antibody Fragments Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Antibody Fragments Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AbbVie
  2. 6.1.1 AbbVie Company Information
  3. 6.1.2 AbbVie Business Overview
  4. 6.1.3 AbbVie Antibody Fragments Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AbbVie Antibody Fragments Product Portfolio
  6. 6.1.5 AbbVie Recent Developments
  7. 6.2 Amgen
  8. 6.2.1 Amgen Company Information
  9. 6.2.2 Amgen Business Overview
  10. 6.2.3 Amgen Antibody Fragments Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Amgen Antibody Fragments Product Portfolio
  12. 6.2.5 Amgen Recent Developments
  13. 6.3 Biogen
  14. 6.3.1 Biogen Company Information
  15. 6.3.2 Biogen Business Overview
  16. 6.3.3 Biogen Antibody Fragments Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Biogen Antibody Fragments Product Portfolio
  18. 6.3.5 Biogen Recent Developments
  19. 6.4 Bristol-Myers Squibb
  20. 6.4.1 Bristol-Myers Squibb Company Information
  21. 6.4.2 Bristol-Myers Squibb Business Overview
  22. 6.4.3 Bristol-Myers Squibb Antibody Fragments Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bristol-Myers Squibb Antibody Fragments Product Portfolio
  24. 6.4.5 Bristol-Myers Squibb Recent Developments
  25. 6.5 F. Hoffmann-La Roche
  26. 6.5.1 F. Hoffmann-La Roche Company Information
  27. 6.5.2 F. Hoffmann-La Roche Business Overview
  28. 6.5.3 F. Hoffmann-La Roche Antibody Fragments Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 F. Hoffmann-La Roche Antibody Fragments Product Portfolio
  30. 6.5.5 F. Hoffmann-La Roche Recent Developments
  31. 6.6 Eli Lilly
  32. 6.6.1 Eli Lilly Company Information
  33. 6.6.2 Eli Lilly Business Overview
  34. 6.6.3 Eli Lilly Antibody Fragments Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Eli Lilly Antibody Fragments Product Portfolio
  36. 6.6.5 Eli Lilly Recent Developments
  37. 6.7 Novartis
  38. 6.7.1 Novartis Company Information
  39. 6.7.2 Novartis Business Overview
  40. 6.7.3 Novartis Antibody Fragments Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Novartis Antibody Fragments Product Portfolio
  42. 6.7.5 Novartis Recent Developments
  43. 6.8 Johnson & Johnson
  44. 6.8.1 Johnson & Johnson Company Information
  45. 6.8.2 Johnson & Johnson Business Overview
  46. 6.8.3 Johnson & Johnson Antibody Fragments Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Johnson & Johnson Antibody Fragments Product Portfolio
  48. 6.8.5 Johnson & Johnson Recent Developments
  49. 6.9 Sanofi
  50. 6.9.1 Sanofi Company Information
  51. 6.9.2 Sanofi Business Overview
  52. 6.9.3 Sanofi Antibody Fragments Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sanofi Antibody Fragments Product Portfolio
  54. 6.9.5 Sanofi Recent Developments
  55. 6.10 Takeda Pharmaceutical
  56. 6.10.1 Takeda Pharmaceutical Company Information
  57. 6.10.2 Takeda Pharmaceutical Business Overview
  58. 6.10.3 Takeda Pharmaceutical Antibody Fragments Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Takeda Pharmaceutical Antibody Fragments Product Portfolio
  60. 6.10.5 Takeda Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Antibody Fragments Sales by Country
  2. 7.1.1 North America Antibody Fragments Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antibody Fragments Sales by Country (2021-2026)
  4. 7.1.3 North America Antibody Fragments Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antibody Fragments Market Size by Country
  6. 7.2.1 North America Antibody Fragments Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antibody Fragments Market Size by Country (2021-2026)
  8. 7.2.3 North America Antibody Fragments Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antibody Fragments Sales by Country
  2. 8.1.1 Europe Antibody Fragments Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antibody Fragments Sales by Country (2021-2026)
  4. 8.1.3 Europe Antibody Fragments Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antibody Fragments Market Size by Country
  6. 8.2.1 Europe Antibody Fragments Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antibody Fragments Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antibody Fragments Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antibody Fragments Sales by Country
  2. 9.1.1 Asia-Pacific Antibody Fragments Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antibody Fragments Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antibody Fragments Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antibody Fragments Market Size by Country
  6. 9.2.1 Asia-Pacific Antibody Fragments Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antibody Fragments Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antibody Fragments Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antibody Fragments Sales by Country
  2. 10.1.1 South America Antibody Fragments Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antibody Fragments Sales by Country (2021-2026)
  4. 10.1.3 South America Antibody Fragments Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antibody Fragments Market Size by Country
  6. 10.2.1 South America Antibody Fragments Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antibody Fragments Market Size by Country (2021-2026)
  8. 10.2.3 South America Antibody Fragments Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antibody Fragments Sales by Country
  2. 11.1.1 Middle East and Africa Antibody Fragments Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antibody Fragments Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antibody Fragments Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antibody Fragments Market Size by Country
  6. 11.2.1 Middle East and Africa Antibody Fragments Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antibody Fragments Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antibody Fragments Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antibody Fragments Value Chain Analysis
  2. 12.1.1 Antibody Fragments Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antibody Fragments Production Mode & Process
  7. 12.2 Antibody Fragments Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antibody Fragments Distributors
  10. 12.2.3 Antibody Fragments Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst